login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Biasi calls time on carotid stenting


Friday, 20 Feb 2009 10:24



A standard time limit for carotid artery stenting procedures was suggested by Giorgio Biasi of the University of Milano-Bicocca, Italy, speaking at the International Congress on Endovascular Interventions XXII in Scottsdale, Arizona, USA, this month.


Biasi presented the final results of the RISC study (Registro Italiano per lo Stenting Carotideo), a study of 1,350 cases, which found that the minimally-invasive procedure has good long-term results, both in terms of neurological complications and restenosis.


The study aimed to collect data on carotid artery stenting in a "real world" setting.


The data was compiled by professionals from across disciplines concerned with preventing stroke due to carotid plaques. "The interesting point is," said Biasi, "that the major components - vascular surgeons, radiologists and cardiologists - were roughly equally represented."


Each of the study centres was free to use different techniques and devices.


Patient follow-up took place at one, six, 12 and 24 months with computed tomography or magnetic resonance imaging, always in the presence of an independent neurologist. The primary endpoints of the study were 30-day combined any stroke and death rate, restenosis at 24 months, and stroke and death rate at 24 months.


The study found a 30-day stroke and death rate of 2.4%. Biasi highlighted a peak in complication rates in patients aged between 70 and 80 years, which fell in those over 80 years of age.


A difference between experienced and inexperienced centres (those that had performed more or less than 30 procedures respectively) was observed, but this, he said, was not found to be significant (p=.09). He also showed that the data strongly supported statin administration and the use of embolic protection devices.


"The total procedure time was very important. When the time was over 60 minutes, there was a great difference from those taking less than 30 minutes," he said.


"The presence of calcified plaques is also very important [increasing the chance of stroke and death], and the least important factor is the percentage of stenosis."


The study found no statistically significant difference between open and closed cell stent designs.


Beyond 30 days, there were 23 deaths up to two years, 15 of which were from non-neurological causes. There were 13 strokes recorded in this period and a rate of new restenosis of 4.4%.




Add New Comment

Most popular


First patient enrolled in US study of Novate’s Sentry IVC filter
Monday, 22 Sep 2014
Novate Medical has announced that Souheil Saddekni, professor of Vascular and Interventional Radiology at the University of Alabama, Birmingham, USA, has enrolled the first patient in the SENTRY IDE ... First patient enrolled in US study of Novate’s Sentry IVC filter

First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

CIRSE 2014 audience needs more evidence before they support drug-elution in the superficial femoral artery
Friday, 26 Sep 2014
The audience in the CIRSE 2014 “Controversies in superficial femoral artery treatment” session failed to endorse two motions pertaining to drug-elution in this anatomical segment in the annual ... CIRSE 2014 audience needs more evidence before they support drug-elution in the superficial femoral artery

Features


What the trials have taught us about aggressive therapy of deep venous thrombosis
Thursday, 25 Sep 2014
Although current evidence in favour of catheter-directed thrombolysis for deep venous thrombosis may not be robust enough to allow for a shift in clinical practice, that may soon change with strict ... What the trials have taught us about aggressive therapy of deep venous thrombosis

The promise of chemical renal denervation
Friday, 05 Sep 2014
Tim A Fischell writes that chemical renal denervation using ethanol may have numerous advantages over energy-based “burning” technologies. The promise of chemical renal denervation

Profiles


José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions